Print Page   |   Contact Us   |   Your Cart   |   Report Abuse   |   Sign In   |   Apply for NAQC Membership
Site Search
Sign up for NAQC membership today!

Receive a monthly issue of Connections!
NAQC Newsroom: Tobacco Control

FDA Statement on the Institute of Medicine Report: Scientific Standards for Studies on Modified Risk

Wednesday, January 11, 2012  
Posted by: Natalia Gromov

On December 14, 2011, the Institute of Medicine released a report on the design and conduct of studies which the FDA will take into consideration in the assessment and ongoing review of modified risk tobacco products. A modified risk tobacco product is any tobacco product sold or distributed for use to lower the harm or risk of tobacco-related disease associated with other tobacco products. Experts within the FDA’s Center for Tobacco Products will take these recommendations into consideration in developing its guidance and/or regulation on the scientific evidence required for the assessment and ongoing review of modified risk tobacco products.

The 2009 Family Smoking Prevention and Tobacco Control Act requires the FDA to consult with the IOM on the design and conduct of studies and surveillance required for the assessment and ongoing review of modified risk tobacco products. The FDA must publish regulations and/or guidance on the scientific evidence required for assessment and ongoing review of modified risk tobacco products by April 2012.

For more information:


Sign In


Forgot your password?

Not a NAQC Member?

Latest News
Calendar

The upcoming calendar is currently empty.

Click here to view past events and photos »

Membership 11 years!.

    3219 E. Camelback Road, #416, Phoenix, AZ 85018 | Ph: 800.398.5489 | Fax: 800.398.5489 | email: naqc@naquitline.org